<DOC>
	<DOCNO>NCT00190411</DOCNO>
	<brief_summary>Ehlers-Danlos syndrome vascular type ( EDS-IV ) cause genetic defect collagen type III . Patient die ( median 40 yr ) vascular complication . There treatment . We show artery thin overloaded patient . We test protective effect celiprolol cardiovascular event 5 year , randomize , PROBE design</brief_summary>
	<brief_title>Celiprolol Patients With Ehlers-Danlos Syndrome , Vascular Type</brief_title>
	<detailed_description>100 patient verified EDS-IV syndrome include . Patients randomize either celiprolol ( 50 400 mg BID ) treatment . Patients randomized enter longitudinal survey event . The hypothesis 50 % reduction occurrence cardiovascular event treatment , assess blind , independent event committee .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ehlers-Danlos Syndrome</mesh_term>
	<mesh_term>Abnormalities , Multiple</mesh_term>
	<mesh_term>Chromosome Deletion</mesh_term>
	<mesh_term>Intellectual Disability</mesh_term>
	<mesh_term>Craniofacial Abnormalities</mesh_term>
	<mesh_term>Celiprolol</mesh_term>
	<criteria>Proven disease , No betablocker inclusion previous CV event Exclusion criterion : Criteria inclusion RIGHTEOUS group : Patient already present arterial break dissection treat ( handle ) bétâblocking ( surround ) . Against indication use CELIPROLOL : Unchecked cardiac insufficiency treatment cardiogenic shock BAV 2nd 3rd sail degree angor Prinzmetal disease sine bradycardia pheochromocytoma untreated low blood pressure sentimentality CELIPROLOL Antecedent anaphylactic reaction myasthenia treatment FLOCTAFENINE ( Idarac ) , Sultopride ( interaction ) In two case , patient include group follow troop . Criteria inclusion group : Refusal participate study . Impossibility move . Pregnancy Woman age procreate without mean effective contraception .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Arteries</keyword>
	<keyword>ultrasonography</keyword>
	<keyword>Ehlers Danlos syndrome</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>beta adrenergic antagonist</keyword>
</DOC>